share_log

金迪克(688670.SH):公司冻干人用狂犬病疫苗(Vero细胞)已完成III期临床试验并取得临床总结报告

Kim Dick (688670.SH): The company's freeze-dried human rabies vaccine (Vero cells) has completed phase III clinical trials and obtained clinical summary reports

Gelonghui Finance ·  Nov 24, 2023 03:22

Gelonghui, November 24|Kim Dick (688670.SH) said on the investor interactive platform that the company's freeze-dried human rabies vaccine (Vero cells) has completed phase III clinical trials and obtained clinical summary reports. Due to the strict science of new drug registration and a long review cycle, the company is reporting to the national CDE in accordance with the procedures.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment